Medtronic ranked #3 Holder of Pervasive Neurotech Intellectual Property*

One of the world’s largest med­ical tech­nol­o­gy com­pa­nies, Medtron­ic man­u­fac­tures devices to treat car­dio­vas­cu­lar, dia­betes, and mus­cu­loskele­tal con­di­tions, in addi­tion to neu­ro­log­i­cal con­di­tions. Medtron­ic’s Neu­ro­mod­u­la­tion busi­ness includes Deep Brain Stim­u­la­tion, Spinal Cord Stim­u­la­tion, Gas­tric Stim­u­la­tion, and Sacral Stim­u­la­tion divisions.

• Loca­tion: Min­neapo­lis, MN
• Stock Tick­er: NYSE: MDT
• Num­ber of employ­ees: 10,000+
• Per­va­sive neu­rotech US patent grants: 80
• Per­va­sive neu­rotech US pend­ing appli­ca­tions: 85

*Medtron­ic ranks #3 in Sharp­Brains’ Per­va­sive Neu­rotech IP Strength Index, thanks to patents such as:

• US8187181: Scor­ing of sensed neu­ro­log­i­cal sig­nals for use with a med­ical device system
• US8121694: Ther­a­py con­trol based on a patient move­ment state
• US8209009: Sys­tem and method for seg­ment­ing a car­diac sig­nal based on brain stimulation
• US7155278: Neu­rostim­u­la­tion to treat effects of sleep apnea

To learn more about Sharp­Brains’ take on the orga­ni­za­tion’s #Per­va­siveNeu­rotech IP port­fo­lio, and over­all data and trends, click on Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment, and Busi­ness.